Sign in Subscribe
Class action lawsuits

Sarepta Therapeutics, Inc. Faces Securities Lawsuit Over Alleged Securities Fraud

Strategic Insights

— 1 min read

Allegations of false statements and concealed information surrounding ELEVIDYS, a prescription gene therapy for Duchenne, have led to a class action securities lawsuit against Sarepta Therapeutics, Inc. The lawsuit seeks to recover losses for shareholders who were affected by the alleged securities fraud between June 22, 2023, and June 24, 2025. The complaint claims that Sarepta's positive statements about the therapy's safety were misleading and lacked a reasonable basis, given the severity of adverse events and regulatory scrutiny.

Key Takeaways:

  • A class action securities lawsuit was filed against Sarepta Therapeutics, Inc. alleging securities fraud related to ELEVIDYS, a gene therapy for Duchenne.
  • The lawsuit claims that Sarepta made false statements and concealed the severity of adverse events from ELEVIDYS treatment, posing significant safety risks to patients.
  • The complaint alleges that Sarepta's positive statements about the therapy's safety were misleading and lacked a reasonable basis, leading to increased regulatory scrutiny and risk.
  • The lawsuit seeks to recover losses for shareholders who suffered from the alleged securities fraud between June 22, 2023, and June 24, 2025.
  • Levi & Korsinsky, LLP, a nationally-recognized securities litigation firm, is representing the plaintiffs in the case.
  • The firm has a track record of winning high-stakes cases and securing hundreds of millions of dollars for aggrieved shareholders.

Statistics:

  • June 22, 2023: The date marking the beginning of the alleged securities fraud period.
  • June 24, 2025: The date marking the end of the alleged securities fraud period.
  • 20 years: The duration of Levi & Korsinsky's expertise in securities litigation.
  • 7 years: The number of consecutive years Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States.

Sources:

  • https://zlk.com/pslra-1/sarepta-lawsuit-submission-form?prid=162028&wire=5&utm_campaign=11
  • https://www.youtube.com/watch?v=-0bXemw_A3s
  • Newsfile Corp. - August 18, 2025
  • Levi & Korsinsky, LLP (https://zlk.com/)

Read more